Based on the PD1+ Tfh findings suggestive for a tumor associated humoral activation of the TDLN, we speculated that CD8+ cells as possible cytotoxic counterparts might be correlated with improved patients’ survival. The gene discussed is CD8A; the disease is neoplasm.